Artemia sp. as a DNA vaccine vector for common carp Cyprinus carpio larvae by Sri Nuryati, Sekar Sulistyaning Hadiwibowo, . Alimuddin

“…Bacteria containing plasmid Krt-GP-11 as vaccine is served through Artemia sp. as a vector. …”
Get full text

Understanding Human Papillomavirus Vaccination Hesitancy in Japan Using Social Media: Content Analysis by Junyu Liu, Qian Niu, Momoko Nagai-Tanima, Tomoki Aoyama

“… BackgroundDespite the reinstatement of proactive human papillomavirus (HPV) vaccine recommendations in 2022, Japan continues to face persistently low HPV vaccination rates, which pose significant public health challenges. …”
Get full text

Mathematical Modelling of COVID-19 Transmission Dynamics with Vaccination: A Case Study in Ethiopia by Sileshi Sintayehu Sharbayta, Henok Desalegn Desta, Tadesse Abdi

“…In this work, we consider a mathematical model of COVID-19 transmission with double-dose vaccination strategy to control the disease. For the analytical analysis purpose, we divided the model into two parts: model with vaccination and without vaccination. …”
Get full text

Towards a Rational Design of an Asymptomatic Clinical Herpes Vaccine: The Old, the New, and the Unknown by Aziz Alami Chentoufi, Elizabeth Kritzer, David M. Yu, Anthony B. Nesburn, Lbachir BenMohamed

“…The best hope of controlling the herpes simplex virus type 1 and type 2 (HSV-1 and HSV-2) pandemic is the development of an effective vaccine. However, in spite of several clinical trials, starting as early as 1920s, no vaccine has been proven sufficiently safe and efficient to warrant commercial development. …”
Get full text

Knowledge and Attitudes Regarding Human Papillomavirus Vaccination Among Future Healthcare Workers in Serbia by Nemanja Maletin, Nikola Denda, Ana Ljubičić, Radmila Velicki, Aleksandra Patić, Zoran Golušin, Tihomir Dugandžija, Vladimir Petrović, Mioljub Ristić, Vladimir Vuković

Subjects: Get full text

Targeting PCSK9, through an innovative cVLP-based vaccine, enhanced the therapeutic activity of a cVLP-HER2 vaccine in a preclinical model of HER2-positive mammary carcinoma by Laura Scalambra, Francesca Ruzzi, Olga Maria Pittino, Maria Sofia Semprini, Chiara Cappello, Stefania Angelicola, Arianna Palladini, Patrizia Nanni, Louise Goksøyr, Cyrielle Fougeroux, Manuel L. Penichet, Adam Frederik Sander, Pier-Luigi Lollini

Subjects: Get full text

Safety and immunogenicity of Ad26.COV2.S in adolescents: Phase 2 randomized clinical trial by Jelena Tica, Veronica V. Rezelj, Benoit Baron, Vitalija van Paassen, Javier Zaidman, Lee Fairlie, Gert Scheper, Mathieu Le Gars, Frank Struyf, Macaya Douoguih, Javier Ruiz-Guiñazú

Subjects: Get full text

Effectiveness of a 2-dose varicella vaccination program in Changzhou, China, during the transitional period (2017–2022): a registry-based case-cohort study by Suting Xiong, Changlei Han, Dan Wu, Xiaomeng Mi, Peipei Zhang, Han Gao, Gan Cao, Fang Yao, Cong Chen, Xufeng Lv

Subjects: “…Varicella Vaccine (VarV)…”
Get full text

Evaluating the Effectiveness of mRNA-1273.815 Against COVID-19 Hospitalization Among Adults Aged ≥ 18 Years in the United States by Amanda Wilson, Neloufar Rahai, Ekkehard Beck, Elisha Beebe, Brian Conroy, Daina Esposito, Priya Govil, Hagit Kopel, Tianyi Lu, James Mansi, Morgan A. Marks, Katherine E. Mues, Rohan Shah, Michelle Skornicki, Tianyu Sun, Astra Toyip, Mitra Yousefi, David Martin, Andre B. Araujo

Subjects: Get full text

Identification and genetic analysis of the recent Avian pox viruses from infected pigeons and chickens by Amira M. Helal, Osama Mahana, Ali Zanaty, Karim Selim, Mohamed. E. Taha, Mostafa M. Saleh, Mohamed I. Hassan, Mona S. Abdallah

Subjects: Get full text

Immunogenicity of Type IV Pilin Proteins from <i>Clostridium perfringens</i> in Chickens by Audrey Charlebois, Nicolas Deslauriers, Lila Maduro, Martine Boulianne

Subjects: Get full text

Comprehensive Insights into Monkeypox (mpox): Recent Advances in Epidemiology, Diagnostic Approaches and Therapeutic Strategies by Suresh Kumar, Dhanyashri Guruparan, Kalimuthu Karuppanan, K. J. Senthil Kumar

Subjects: Get full text

Toward trustworthy COVID-19 interventions: Building vaccine trust through community-university partnerships. by Laura A Bray, Lori L Jervis, Amanda E Janitz, Laura Ross, Gloria Tallbull, Timothy M VanWagoner, CATCH-UP Vaccines Team

“…Prior research identifies trust as critical to increase vaccine acceptance and uptake. However, few intervention studies have sought to develop or test strategies for bolstering vaccine-related trust. …”
Get full text

SHASI-ML: a machine learning-based approach for immunogenicity prediction in Salmonella vaccine development by Ottavia Spiga, Ottavia Spiga, Ottavia Spiga, Anna Visibelli, Francesco Pettini, Bianca Roncaglia, Annalisa Santucci, Annalisa Santucci, Annalisa Santucci

Subjects: Get full text

Immune responses of cattle vaccinated by various routes with Mycobacterium bovis Bacillus Calmette-Guérin (BCG) by Mitchell V. Palmer, Soyoun Hwang, Carly Kanipe, Ellie J. Putz, Luis Guilherme Virgilio Fernandes, Anna Didkowska, Paola M. Boggiatto

“…Abstract Background Mycobacterium bovis BCG is the human tuberculosis vaccine and is the oldest vaccine still in use today with over 4 billion people vaccinated since 1921. …”
Get full text

Staphylococcus aureus-specific TIGIT+ Treg are present in the blood of healthy subjects – a hurdle for vaccination? by Jonah Clegg, Jonah Clegg, Malgorzata E. Mnich, Malgorzata E. Mnich, Alberto Carignano, Giovanni Cova, Simona Tavarini, Chiara Sammicheli, Bruna Clemente, Megan Smith, Megan Smith, Emilio Siena, Monia Bardelli, Michela Brazzoli, Fabio Bagnoli, Rachel M. McLoughlin, Elisabetta Soldaini

Subjects: Get full text

COVID-19 vaccine for people who live and work in prisons worldwide: A scoping review. by Nasrul Ismail, Lara Tavoschi, Babak Moazen, Alicia Roselló, Emma Plugge

“…Overcrowding, poor conditions, and high population turnover make prisons highly susceptible to COVID-19. Vaccination is key to controlling COVID-19, yet there is disagreement regarding whether people who live and work in prisons should be prioritised in national vaccination programmes. …”
Get full text

Development of Delivery Systems Enhances the Potency of Cell-Based HIV-1 Therapeutic Vaccine Candidates by Amin Hadi, Abbas Rastgoo, Maryam Eskandarian, Nooshin Haghighipour, Azam Bolhassani

“…Among different vaccination strategies, cell-based vaccines could achieve in clinical trials. …”
Get full text

Author Correction: AI based predictive acceptability model for effective vaccine delivery in healthcare systems by Muhammad Shuaib Qureshi, Muhammad Bilal Qureshi, Urooj Iqrar, Ali Raza, Yazeed Yasin Ghadi, Nisreen Innab, Masoud Alajmi, Ayman Qahmash

Get full text

A Study to Assess the Attitude and Acceptance toward COVID-19 Vaccine among General Public by Bijitha Biju, M. Melvin David, J. Balalakshmi

Subjects: Get full text